
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | 11:11 Capital Corp. |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
0.0%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.1%
|
Data since: Apr-1-2009 Current Portfolio: Q4 2009
|
|
|
|
|
| Not enough data to generate similar portfolios. Please check back later. |
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ALKS |
$18.47 |
-0.41 |
-2.17% |
572,679 |
56% |
$2.4B |
- |
56% |
-8% |
+96.3% |
$8.3M | 950.0K shares - New Holding
No Alerts/News
|
|
|
| BMRN |
$38.05 |
+0.29 |
+0.77% |
1,743,043 |
177% |
$4.3B |
- |
65% |
-2% |
+102.3% |
$17.0M | 986.5K shares - decrease of 8.5K shares
No Alerts/News
|
|
|
| BSX |
$5.95 |
0.00 |
0.00% |
9,073,220 |
62% |
$8.9B |
- |
19% |
-25% |
-33.9% |
$45.4M | 5.2M shares - increase of 4.8M shares
No Alerts/News
|
|
|
| CBST |
$40.34 |
-0.50 |
-1.22% |
1,353,287 |
151% |
$2.5B |
- |
89% |
-5% |
+112.7% |
$17.4M | 958.6K shares - New Holding
No Alerts/News
|
|
|
| DNDN |
$14.78 |
-0.49 |
-3.21% |
9,517,204 |
75% |
$2.3B |
- |
129% |
-66% |
-43.8% |
$8.2M | 300.0K shares - increase of 299.0K shares
2 Alerts (1 News) - View
|
|
|
| ELN |
$13.17 |
-0.27 |
-2.01% |
4,225,211 |
117% |
$8.0B |
- |
116% |
-9% |
+102.0% |
$10.4M | 1.6M shares - increase of 763.4K shares
1 Alert (0 News) - View
|
|
|
| ENZN |
$7.65 |
-0.08 |
-1.03% |
99,084 |
64% |
$371.7M |
- |
25% |
-35% |
-27.4% |
$13.5M | 1.4M shares - decrease of 713.0K shares
No Alerts/News
|
|
|
| UTHR |
$49.41 |
-0.49 |
-0.98% |
981,851 |
111% |
$2.9B |
- |
35% |
-30% |
-6.2% |
$18.3M | 399.5K shares - decrease of 390.5K shares
No Alerts/News
|
|
|
| XNPT |
$4.56 |
+0.06 |
+1.33% |
90,338 |
37% |
$158.8M |
- |
32% |
-60% |
-75.4% |
$7.9M | 450.0K shares - New Holding
No Alerts/News
|
|
|
| [ABII] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$13.9M | 385.6K shares - decrease of 33.2K shares
No Alerts/News
|
|
|
| [CEPH] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$50.9M | 892.3K shares - increase of 142.3K shares
1 Alert (0 News) - View
|
|
|
| [EM] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$16.8M | 1.1M shares - increase of 288.9K shares
1 Alert (0 News) - View
|
|
|
| [GENZ] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$14.3M | 277.1K shares - increase of 276.1K shares
No Alerts/News
|
|
|
| [KG] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$17.0M | 1.5M shares - decrease of 444.3K shares
No Alerts/News
|
|
|
| [OSIP] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$10.7M | 323.0K shares - New Holding
No Alerts/News
|
|
|
|
|
Discuss 11:11 Capital Corp. 's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Trading Ideas For A Market Pullback AMSC SPY NFLX COCO DNDN XLF XHB XBI DIA
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 09, 04:30PM from (www.benzinga.com) The stock market has had one of its best annual starts in history in 2012. The S&P 500 is already up a whopping 7.51%
Flag
Post a comment
BioMarin to Present at the BIO CEO & Investor Conference BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 07, 09:00AM from (www.globenewswire.com) NOVATO, Calif., Feb. 7, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques
Flag
Post a comment
24/7 Wall St. Closing Bell GLW CMA HUM L SYY WY IDTI PCL CHUX GBG MCK SURW FDX SOHU DNDN LAZ CYOU
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 06, 04:07PM from (247wallst.com) US equity markets opened lower this morning and never moved into positive territory all day. Greek debt swap negotiations
Flag
Post a comment
Dendreon Rockets 17% After Critical Reveiw For Amgen's Cancer Drug AMGN DNDN
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 06, 03:47PM from (www.benzinga.com) Shares of Dendreon (NASDAQ: DNDN) are surging on Monday after federal health regulators published a critical review for a
Flag
Post a comment
24/7 Wall St. Closing Bell BCO MRK QCOM DELL LEA EDMC BSX GMCR BZH AKS TTWO DO BIOS STLD BRCM EW NDAQ RGDX MNOV URG ZNGA VIAB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - February 02, 04:08PM from (247wallst.com) All three major US stock indexes opened higher this morning, and spent the rest of the day bouncing around the neutral line.
Flag
Post a comment
Amylin Pharmaceuticals Continues to Soar in Wake of Bydureon Approval LLY ALKS AMLN GS JEF DB
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - February 02, 01:49PM from (www.benzinga.com) Last Friday, the FDA finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals (NASDAQ:
Flag
Post a comment
Zimmer Holdings Still Struggling To Grow ABT MDT SYK BSX ZMH
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - January 31, 02:18PM from (stocks.investopedia.com) Zimmer is experiencing modest growth, but is struggling to grow as much as companies that offer heart-related medical de
Flag
Post a comment
24/7 Wall St. Top Analyst Calls of the Week JPM MCD KLAC T BBY GS CHK MS ETFC NFLX LIFE JEF DNDN JCP VPRT ZNGA KORS
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 28, 10:19AM from (247wallst.com) This last week brought many new analyst calls in key stocks. At the end of each week we review research calls looking for
Flag
Post a comment
Alkermes, Amylin, Delta Air, US Airways: U.S. Equity Preview DAL LCC ALKS AMLN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - January 27, 06:02PM from (www.bloomberg.com) Shares of the following companies may have unusual moves in U.S. trading on Jan. 30. Stock symbols are in parentheses, and prices are as of 5 p.m. in New York.
Flag
Post a comment
Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval LLY NVO ALKS AMLN
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - January 27, 05:34PM from (feeds.nytimes.com) The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the
Flag
Post a comment
Abbott Labs Dividing Its Growth And Income Potential ABT MDT JNJ BSX MJN
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - January 26, 02:09PM from (stocks.investopedia.com) With the coming split of operations, Abbott Labs investors will better be able to choose between growth and income.
Flag
Post a comment
Tracking The Unusual Short Interest Trends F BAC ALU HGSI SIRI GMCR NFLX RIMM DNDN FSLR DMND LNKD
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 26, 10:08AM from (247wallst.com) Cult stocks and controversial stocks often have an unusually high short interest. What is amazing is that the bets against
Flag
Post a comment
Dwarfism Meds Shows Lure of Rare-Disease Drugs BMRN CAVM
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - January 23, 02:39PM from (www.bloomberg.com) Enlarge image
Dwarfism Medicine Shows Lure of $400,000 Rare-Disease Drugs
The U.S. and
Flag
Post a comment
2012 Top Picks From... Everyone! BA GE STJ AAPL T BSX ETFC ISRG KFT DNDN MCP
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 10, 07:25AM from (247wallst.com) 24/7 has compiled many of the predictions from various firms and various market pundits for what lies ahead in 2012. Wall
Flag
Post a comment
24/7 Wall St. Closing Bell AA XOM MRK COST CBST SCCO NFLX THRX AKAM IDIX LTRX AYI INHX PSOF P
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - January 09, 04:07PM from (247wallst.wordpress.com) US markets opened up slightly this morning and have maintained a slight positive tone for most of the day. Today marks the
Flag
Post a comment
|
|